Goldman Sachs announced that qualified U.S. firms can subscribe to its $105 billion Financial Square Treasury Instruments Fund through Lynq, a private settlement network running on the Avalanche blockchain. However, the fund shares are not tokenized; Lynq only provides an alternative access and settlement route for the existing institutional share class. This move does not open the fund to retail investors or European clients and does not directly impact the Avalanche (AVAX) token price, which rose on expectations rather than actual volume shifts. The announcement highlights cautious blockchain adoption in institutional finance without disrupting existing fund structures.
Goldman Sachs' new fund access via Avalanche blockchain is the subject, with Pluang market data as context. As of Sep 30, 2026 07:02 WIB, among 50 major cryptocurrencies priced on Pluang, 22 rose and 27 fell. Notable movers include COMP at Rp439.668 with a 3.98% increase and a typical hold time of 97 days, XLM at Rp3.998 down 3.96% with 80% buy order activity, and SUSHI at Rp4.713 up 3.55% with a 101-day hold time.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
